Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Breakthrough Therapy for Type 2 Immune Indications: the Ten Billion dollars drug Dupilumab will be marketed in China

PharmaSources/1℃June 19, 2020

Tag: Breakthrough Therapy , Type 2 Immune Indications , Dupilumab , Sanofi

PharmaSources Customer Service